This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Charitharth Vivek Lal: Innovator in Respiratory Probiotics
Introduction
Charitharth Vivek Lal is an accomplished inventor based in Birmingham, AL (US). He has made significant contributions to the field of respiratory health through his innovative research and patents. With a total of 3 patents, Lal is dedicated to improving the lives of individuals suffering from lung diseases.
Latest Patents
Lal's latest patents focus on inhaled respiratory probiotics for lung diseases affecting individuals from infancy to adulthood. His research has characterized the respiratory microbiomes of neonates and those with bronchopulmonary disease. The probiotic compositions he has developed can include at least one living bacterial strain and at least one killed bacterial strain. These compositions, when delivered to the bronchi or lungs of a patient, can provide a reduction in the symptoms of bronchopulmonary diseases.
Career Highlights
Charitharth Vivek Lal is associated with the UAB Research Foundation at the University of Alabama at Birmingham. His work at this esteemed institution has allowed him to explore innovative solutions for respiratory health challenges. His dedication to research and development has positioned him as a key figure in the field.
Collaborations
Lal has collaborated with notable colleagues, including Namasivayam Ambalavanan and Amit Gaggar. These partnerships have further enhanced his research efforts and contributed to the advancement of respiratory health solutions.
Conclusion
Charitharth Vivek Lal is a pioneering inventor whose work in inhaled respiratory probiotics is making a significant impact on lung health. His innovative approach and dedication to research continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
